Skp to main content
30 Oct 2020
29 Oct 2020
UCB Presents Nine Abstracts at EADV 2020, Showcasing Ongoing Commitment to Dermatology
Read More
23 Oct 2020
22 Oct 2020
UCB’s anti-epileptic drug VIMPAT[®] (lacosamide) receives EU CHMP positive opinion for primary generalised tonic-clonic seizures
Read More
16 Oct 2020
UCB FURTHER INVESTS IN UK OPERATIONS WITH AGREEMENT TO ACQUIRE A NEW LEADING-EDGE CAMPUS
Read More
9 Oct 2020
2 Oct 2020
2 Oct 2020
Changes in UCB's Board of Directors
Read More
25 Sep 2020
22 Sep 2020
UCB Achieves Important Regulatory Milestone for Bimekizumab
Read More
Subscribe to
